We are live on ! Find out more
DH icon

Definitive Healthcare

123 hedge funds and large institutions have $1.69B invested in Definitive Healthcare in 2022 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 57 increasing their positions, 26 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,658% more call options, than puts

Call options by funds: $331K | Put options by funds: $12K

119% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 26

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

40% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 20

6% more funds holding

Funds holding: 116123 (+7)

1.6% more ownership

Funds ownership: 106.69%108.29% (+1.6%)

29% less capital invested

Capital invested by funds: $2.39B → $1.69B (-$699M)

Holders
123
Holders Change
+7
Holders Change %
+6.03%
% of All Funds
2.12%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
28
Increased
57
Reduced
26
Closed
20
Calls
$331K
Puts
$12K
Net Calls
+$319K
Net Calls Change
+$124K

DH Hedge Fund Activity: Q3 2022 in Review

123 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Definitive Healthcare (DH) for Q3 2022, worth a combined $1.69B — down 29% from $2.39B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new DH positions and 20 closed out — a net gain of 8 holders — while 57 added to existing stakes and 26 trimmed.

The largest buyer was Fred Alger Management, adding an estimated $36.7M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $24.6M sold.

  • 123 institutional investors held Definitive Healthcare (DH) as of Q3 2022, up from 116 in Q2 2022.
  • Funds reported $1.69B of Definitive Healthcare stock for Q3 2022, down 29% quarter-over-quarter.
  • 28 funds opened new Definitive Healthcare positions in Q3 2022 and 20 closed out, a net change of +8 holders.
  • The largest Definitive Healthcare buyer in Q3 2022 was Fred Alger Management, an estimated $36.7M added.
  • The largest Definitive Healthcare seller in Q3 2022 was T. Rowe Price Associates, an estimated $24.6M sold.

Based on aggregated 13F filings for Q3 2022.